Article
High expression of ID1 in monocytes is strongly associated with phenotypic and functional MDSC markers in advanced melanoma.
Cancer immunology, immunotherapy : CII - 1 Apr 2020
Melief Jeroen, Pico de Coaña Yago, Maas Roeltje, Fennemann Felix-Lennart, Wolodarski Maria, Hansson Johan, Kiessling Rolf
Abstract excerpt
The efficacy of immunotherapies for malignant melanoma is severely hampered by local and systemic immunosuppression mediated by myeloid-derived suppressor cells (MDSC). Inhibitor of differentiation 1 (ID1) is a transcriptional regulator that was shown to be centrally involved in the induction of immunosuppressive properties in myeloid cells in mice, while it was overexpressed in CD11b+ cells in the blood of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
